Showing 1 - 9 results of 9 for search 'Sharmila Mallya', query time: 0.05s Refine Results
  1. 1
    Toxoplasma gondii Extends the Life Span of Infected Human Neutrophils by Inducing Cytosolic PCNA and Blocking Activation of Apoptotic Caspases

    Toxoplasma gondii Extends the Life Span of Infected Human Neutrophils by Inducing Cytosolic PCNA and Blocking Activation of Apoptotic Caspases by Tatiane S. Lima, Sharmila Mallya, Allen Jankeel, Ilhem Messaoudi, Melissa B. Lodoen

    Published 2021-02-01
    Get full text
    Article
  2. 2
    <named-content content-type="genus-species">Toxoplasma gondii</named-content> Dysregulates Barrier Function and Mechanotransduction Signaling in Human Endothelial Cells

    <named-content content-type="genus-species">Toxoplasma gondii</named-content> Dysregulates Barrier Function and Mechanotransduction Signaling in Human Endothelial Cells by Armond L. Franklin-Murray, Sharmila Mallya, Allen Jankeel, Suhas Sureshchandra, Ilhem Messaoudi, Melissa B. Lodoen

    Published 2020-02-01
    Get full text
    Article
  3. 3
    Toxoplasma gondii activates a Syk-CARD9-NF-κB signaling axis and gasdermin D-independent release of IL-1β during infection of primary human monocytes.

    Toxoplasma gondii activates a Syk-CARD9-NF-κB signaling axis and gasdermin D-independent release of IL-1β during infection of primary human monocytes. by William J Pandori, Tatiane S Lima, Sharmila Mallya, Tiffany H Kao, Lanny Gov, Melissa B Lodoen

    Published 2019-08-01
    Get full text
    Article
  4. 4
    Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1.

    Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1. by Sharmila Mallya, Briana A Fitch, J Scott Lee, Lomon So, Matthew R Janes, David A Fruman

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.

    Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function. by Sung Su Yea, Lomon So, Sharmila Mallya, Jongdae Lee, Kamalakannan Rajasekaran, Subramaniam Malarkannan, David A Fruman

    Published 2014-01-01
    Get full text
    Article
  6. 6
    Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function

    Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function by Honyin Chiu, Roberta Buono, Leandra V. Jackson, Lee-or Herzog, Sharmila Mallya, Crystal S. Conn, Davide Ruggero, David A. Fruman

    Published 2021-07-01
    Get full text
    Article
  7. 7
    Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition

    Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition by Thanh-Trang Vo, Lee-or Herzog, Roberta Buono, Jong-Hoon Scott Lee, Sharmila Mallya, Madeleine R. Duong, Joshua Thao, Moran Gotesman, David A. Fruman

    Published 2021-11-01
    Get full text
    Article
  8. 8
    Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia

    Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia by Bianca J. Lee, Sharmila Mallya, Nuntana Dinglasan, Amos Fung, Tram Nguyen, Lee-or Herzog, Joshua Thao, Edward G. Lorenzana, David Wildes, Mallika Singh, Jacqueline A. M. Smith, David A. Fruman

    Published 2021-08-01
    Get full text
    Article
  9. 9
    The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation

    The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation by Honyin Chiu, Sharmila Mallya, Phuongthao Nguyen, Annie Mai, Leandra V. Jackson, David G. Winkler, Jonathan P. DiNitto, Erin E. Brophy, Karen McGovern, Jeffery L. Kutok, David A. Fruman

    Published 2017-06-01
    Get full text
    Article

Search Tools: